Memorial Sloan Kettering prom gives kids with cancer a chance to celebrate: ‘I feel like a queen'
After being diagnosed with an aggressive and rare carcinoma tumor during her sophomore year in March, 16-year-old Jazzy missed her prom.
Advertisement
But, on Thursday afternoon, the Catskill teen got to walk a red carpet in a pink-beaded ball gown, pose for pics with new bestie and fellow patient Samantha,15, and boogie to 'Shout' and 'Dancing Queen' with her high school boyfriend Liam.
'We get to have our own little prom here,' said Jazzy, who is facing hearing loss from her chemotherapy. 'We have a new family here.'
8 Jazzy (left) and Samantha were thrilled to attend prom at Memorial Sloan Kettering.
Tamara Beckwith
Advertisement
She was one of about 200 people —glammed up patients, families and staffers – in attendance at Memorial Sloan Kettering's Pediatric Prom, which was held in the transformed West Dining Room inside the renowned hospital.
It was the 35th Pediatric Prom, which started as a small dance party in the hospital unit and has grown to an elaborate ball with fancy dresses, a photo booth, DJs, limos, a milk-and-cookies bar, face paint and lots of dancing.
'Our entire team is committed to making it a special and memorable day for everyone involved,' Rachel Corke, the director of hospital administration for MSK Kids, told The Post.
8 Staffers dress up and attend the prom alongside patients.
Tamara Beckwith
Advertisement
Against the backdrop of glittery 'Starry Night' themed decorations, guests sipped ginger ale and juice and enjoyed mac and cheese and burgers that even the doctors OK'ed just this once.
'I don't feel like a princess — I feel like a queen,' exulted 7-year-old Maya in between bites of freshly popped popcorn from a festive cart. The tiara-clad tot has been battling neuroblastoma since she was 3 and underwent surgery two years ago to remove a tumor.
Hospital staff danced alongside their brave young charges.
8 Patient Gini Beltran attended the event with fiance Juan Guillermo.
Tamara Beckwith
Advertisement
'This is everyone's favorite day of the year,' said Melissa Seidner, a 31-year-old administrative supervisor in the pediatric division at MSK. 'It's so fun to see all the patients enjoy themselves. It's a nice break from dealing with what we deal with.'
She wore a jewel green gown that she'd selected from racks of donated dresses in a repurposed hospital rec room turned into 'Promingdale's' by the Society of MSK's Children's Committee.
Maggie Kraus, a 17-year-old from Westchester who was diagnosed with leukemia this past November, rocked a soft purple frock with matching head scarf as she partied the afternoon away.
'I love princess dresses,' she said, vowing to wear it for her upcoming 18th birthday in July. 'I was really nervous I wouldn't be able to experience senior prom. But they pulled through.'
8 The Society of MSK's Children's Committee creates a 'Promingdale's' shop in a repurposed hospital rec room.
Doree Lewak for NY Post
8 Patients and staffers get to choose from racks of donated clothing.
Doree Lewak for NY Post
Kraus was set to start her next round of chemo a few hours after prom, but she didn't let it — and the nausea it would likely bring about — take away from her enjoyment of the event.
'Let me have fun,' she said.
Advertisement
As the song 'I Will Survive' played poignantly in the background, the competitive equestrian relayed how her 'whole world got turned upside down' by her recent diagnosis.
Doctors told her she wouldn't be able to ride horses for two years.
'I proved them wrong and I'm riding,' said the fearless teen, who volunteers to work with younger kids on the spectrum. 'I'm super-scared of needles, but I have to get used to it.'
8 Maggie Kraus was thrilled to find a violet gown.
Tamara Beckwith
Advertisement
She shaved off her flowing brown hair — which she loved to dye bright colors — rather than waiting for the side effects of chemo to cause it to fall out.
'I wanted it to be my doing and not the cancer,' she said.
Pediatric oncologist Dr. Andrew Kung told The Post that the prom exemplifies the philosophy at MSK, whose pediatric cancer center is ranked the best in the country and treats people up to age 40.
'This is one of the most special events for us,' he said. '[We're] not just about curing disease but caring for the patient and family.'
Advertisement
8 The Rodriguez family — 6-year-old Alessia (second from left), mom Maite, dad Diego and little sister Vida — had a great time at the event.
Tamara Beckwith
8 Jon Lyrick hopes to one day volunteer at the event.
Tamara Beckwith
Jon Lyrick was decked out in a show-stopping silver and black suit from Portabella. The 25-year-old from Crown Heights partied with friends as he told The Post that someday he'd 'love to come back to prom as a volunteer.'
Advertisement
Lyrick, who has undergone two bone marrow transplants, is feeling stronger every day.
'I love to have fun,' he told The Post between songs on the dance floor, where he happily spun around friends and IV poles. 'Today is a good day.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Dog dies in extreme Las Vegas heat after woman says she fell asleep, forgot about dog for 20 hours
LAS VEGAS (KLAS) — The woman accused of leaving a dog outside in extreme heat for over 20 hours told police that she fell asleep and forgot about the animal, documents said. On Saturday, May 31, officers with the Las Vegas Metropolitan Police Department responded to the 6800 block of Frances Celia Avenue near Tropicana Avenue and East Russell Road after the Clark County Animal Protection Services requested assistance. The call stated that a dead dog was found in a crate in the backyard of a home there, according to an arrest report. Officers spoke with Olivia Underwood, 30, who told police she was the owner of the dog, a three-year-old Frenchie named Jazzy. Underwood told police she fell asleep and forgot about the dog until it died. RELATED: Woman arrested after dog dies in crate left outside Las Vegas home in extreme heat A witness told police her husband noticed Jazzy was outside in the crate at around 8 a.m. Four hours later, when she got home, the witness noticed the dog was still locked inside the cage and was panting, according to the report. The witness contacted animal protective services as well as her sister-in-law, who lived across the street, to help. The sister-in-law told police she contacted another neighbor to check on the dog with her. She said she checked the weather app on her phone, which said it was 103 degrees, the report stated. They noticed the dog looked like she was not moving. She told police she and the other neighbor were scared to go into the backyard because they were worried about trespassing laws. She said the crate was directly in the sun, and there were empty food and water bowls inside the crate. A third woman came out of her house after seeing the two women looking concerned. She told police she decided to enter the backyard to attempt to help the dog, according to the report. She noticed the dog started having a seizure and was foaming at the mouth. She thought the seizure was heat-related, so she grabbed a bucket of water from her home and poured it over the dog, but the dog was not reacting anymore. She told police she did this three times, but noticed the dog was no longer breathing and 'was stiff,' the report said. After all three women realized the dog was dead, Underwood came out of her home and started yelling at them, telling them to get out of her backyard. Underwood told police that she works overnight 12-hour shifts at a local hospital. She said she put Jazzy outside in the crate on Friday night at around 5:45 p.m., around 20 hours before the dog's death, according to the report. When she left the house, the crate was locked, and there was no way for Jazzy to exit the crate or scratch on the house door to be let inside. She told police she got home at around 7 a.m., but never checked on the dog because she 'just went inside to go sleep,' saying she fell asleep on the couch with her scrubs on from work. She later said she changed into pajamas and went to sleep. 'Olivia had time to get home from work, order an Uber for her grandmother, change into sleeping clothes, and fall asleep, but never checked on 'Jazzy,' who was outside in over 100 [degree] weather,' the report said. Underwood told police one of her kids woke her up at around 1 p.m., saying there were people in the backyard. She went outside to see the women tending to Jazzy. Underwood told police the women started yelling at her for leaving her dog outside, so she cursed them out and told them to 'get the [expletive] out of my house,' the report stated. She said Jazzy's crate was usually inside, but the dog made a mess the night before, so they took it outside to wash it. Underwood told police she was sorry for being so selfish. According to records, Underwood was involved in several other situations with the Animal Protection Services, including an incident in December 2016 where someone complained she left a pit bull on a patio in 35-degree weather. Additionally, in June 2024, Underwood took Jazzy to an animal hospital, but refused all medical care and advice and left, the report stated. Underwood faces a charge of willful or malicious torture, maiming, or killing of a dog, court records show. She was released on bail and is expected in court on July 2. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 hours ago
- Yahoo
Two patients faced chemo. The one who survived got a test to see if it was safe.
JoEllen Zembruski-Ruple, while in the care of New York City's renowned Memorial Sloan Kettering Cancer Center, swallowed the first three chemotherapy pills to treat her squamous cell carcinoma on Jan. 29, her family members said. They didn't realize the drug could kill her. Six days later, Zembruski-Ruple went to Sloan Kettering's urgent care department to treat sores in her mouth and swelling around her eyes. The hospital diagnosed oral yeast infection and sent her home, her sister and partner said. Two days later, they said, she returned in agony — with severe diarrhea and vomiting — and was admitted. 'Enzyme deficiency,' Zembruski-Ruple texted a friend. The 65-year-old, a patient advocate who had worked for the National Multiple Sclerosis Society and other groups, would never go home. Covered in bruises and unable to swallow or talk, she eventually entered hospice care and died March 25 from the very drug that was supposed to extend her life, said her longtime partner, Richard Khavkine. Zembruski-Ruple was deficient in the enzyme that metabolizes capecitabine, the chemotherapy drug she took, said Khavkine and Susan Zembruski, one of her sisters. Zembruski-Ruple was among about 1,300 Americans each year who die from the toxic effects of that pill or its cousin, the IV drug fluorouracil known as 5-FU. Doctors can test for the deficiency — and then either switch drugs or lower the dosage if patients have a genetic variant that carries risk. The FDA approved an antidote in 2015, but it's expensive and must be administered within four days of the first chemotherapy treatment. Newer cancer drugs sometimes include a companion diagnostic to determine whether a drug works with an individual patient's genetics. But 5-FU went on the market in 1962 and sells for about $17 a dose; producers of its generic aren't seeking approval for toxicity tests, which typically cost hundreds of dollars. Doctors have only gradually understood which gene variants are dangerous in which patients, and how to deal with them, said Alan Venook, a colorectal and liver cancer specialist at the University of California-San Francisco. By the time Zembruski-Ruple's doctors told her she had the deficiency, she had been on the drug for eight days, said Khavkine, who watched over his partner with her sister throughout the seven-week ordeal. Khavkine said he 'would have asked for the test' if he had known about it, but added 'nobody told us about the possibility of this deficiency.' Zembruski-Ruple's sister also said she wasn't warned about the fatal risks of the chemo, or told about the test. 'They never said why they didn't test her,' Zembruski said. 'If the test existed, they should have said there is a test. If they said, 'Insurance won't cover it,' I would have said, 'Here's my credit card.' We should have known about it.' Despite growing awareness of the deficiency, and an advocacy group made up of grieving friends and relatives who push for routine testing of all patients before they take the drug, the medical establishment has moved slowly. A panel of the National Comprehensive Cancer Network, or NCCN — specialists from Sloan Kettering and other top research centers — until recently did not recommend testing, and the FDA does not require it. In response to a query from KFF Health News about its policy, Sloan Kettering spokesperson Courtney Nowak said the hospital treats patients 'in accordance with NCCN guidelines.' She said the hospital would not discuss a patient's care. On Jan. 24, the FDA issued a warning about the enzyme deficiency in which it urged health care providers to 'inform patients prior to treatment' about the risks of taking 5-FU and capecitabine. On March 31 — six days after Zembruski-Ruple's death — the network's expert panel for most gastrointestinal cancers took a first step toward recommending testing for the deficiency. Worried that President Donald Trump's FDA might do nothing, Venook said, the panel — whose guidance shapes the practices of oncologists and health insurers — recommended that doctors consider testing before dosing patients with 5-FU or capecitabine. However, its guidance stated that 'no specific test is recommended at this time,' citing a lack of data to 'inform dose adjustments.' Sloan Kettering 'will consider this guidance in developing personalized treatment plans for each patient,' Nowak told KFF Health News. The new NCCN guidance was 'not the blanket recommendation we were working toward, but it is a major step toward our ultimate goal,' said Kerin Milesky, a public health official in Brewster, Massachusetts, who's part of an advocacy group for testing. Her husband, Larry, died two years ago at age 73 after a single treatment of capecitabine. European drug regulators began urging oncologists to test patients for deficiency in May 2020. Patients with potentially risky genetics are started on a half-dose of the cancer drug. If they suffer no major toxicity, the dose is increased. Emily Alimonti, a 42-year-old biotech salesperson in upstate New York, chose that path before starting capecitabine treatment in December. She said her doctors — including an oncologist at Sloan Kettering — told her they didn't do deficiency testing, but Alimonti insisted. 'Nope,' she said. 'I'm not starting it until I get the test back.' The test showed that Alimonti had a copy of a risky gene variant, so doctors gave her a lower dose of the drug. Even that has been hard to tolerate; she's had to skip doses because of low white blood cell counts, Alimonti said. She still doesn't know whether her insurer will cover the test. Around 300,000 people are treated with 5-FU or capecitabine in the United States each year, but its toxicity could well have prevented FDA approval were it up for approval today. Short of withdrawing a drug, however, U.S. regulators have little power to manage its use. And 5-FU and capecitabine are still powerful tools against many cancers. At a January workshop that included FDA officials and cancer specialists, Venook, the NCCN panel's co-chair, asked whether it was reasonable to recommend that doctors obtain a genetic test 'without saying what to do with the result.' But Richard Pazdur, the FDA's top cancer expert, said it was time to end the debate and commence testing, even if the results could be ambiguous. 'If you don't have the information, how do you have counseling?' he asked. Two months later, Venook's panel changed course. The price of tests has fallen below $300 and results can be returned as soon as three days, Venook said. Doubts about the FDA's ability to further confront the issue spurred the panel's change of heart, he said. 'I don't know if FDA is going to exist tomorrow,' Venook told KFF Health News. 'They're taking a wrecking ball to common sense, and that's one of the reasons we felt we had to go forward.' On May 20, the FDA posted a Federal Register notice seeking public input on the issue, a move that suggested it was considering further action. Venook said he often tests his own patients, but the results can be fuzzy. If the test finds two copies of certain dangerous gene variants in a patient, he avoids using the drug. But such cases are rare — and Zembruski-Ruple was one of them, according to her sister and Khavkine. Many more patients have a single copy of a suspect gene, an ambiguous result that requires clinical judgment to assess, Venook said. A full-gene scan would provide more information but adds expense and time, and even then the answer may be murky, Venook said. He worries that starting patients on lower doses could mean fewer cures, especially for newly diagnosed colon cancer patients. Power Should Rest With Patients Scott Kapoor, a Toronto-area emergency room physician whose brother Anil, a much-loved urologist and surgeon, died of 5-FU toxicity at age 58 in 2023, views Venook's arguments as medical paternalism. Patients should decide whether to test and what to do with the results, he said. 'What's better — don't tell the patient about the test, don't test them, potentially kill them in 20 days?' he said. 'Or tell them about the testing while warning that potentially the cancer will kill them in a year?' 'People say oncologists don't know what to do with the information,' said Karen Merritt, whose mother died after an infusion of 5-FU in 2014. 'Well, I'm not a doctor, but I can understand the Mayo Clinic report on it.' The Mayo Clinic recommends starting patients on half a dose if they have one suspect gene variant. And 'the vast majority of patients will be able to start treatment without delays,' Daniel Hertz, a clinical pharmacologist from the University of Michigan, said at the January meeting. Some hospitals began testing after patients died because of the deficiency, said Lindsay Murray, of Andover, Massachusetts, who has advocated for widespread testing since her mother was treated with capecitabine and died in 2021. In some cases, Venook said, relatives of dead patients have sued hospitals, leading to settlements. Kapoor said his brother — like many patients of non-European origin — had a gene variant that hasn't been widely studied and isn't included in most tests. But a full-gene scan would have detected it, Kapoor said, and such scans can also be done for a few hundred dollars. The cancer network panel's changed language is disappointing, he said, though 'better than nothing.' In video tributes to Zembruski-Ruple, her friends, colleagues, and clients remembered her as kind, helpful, and engaging. 'JoEllen was beautiful both inside and out,' said Barbara McKeon, a former colleague at the MS Society. 'She was funny, creative, had a great sense of style.' 'JoEllen had this balance of classy and playful misbehavior,' psychotherapist Anastatia Fabris said. 'My beautiful, vibrant, funny, and loving friend JoEllen.' This article was originally published on
New York Post
23-05-2025
- New York Post
Memorial Sloan Kettering prom gives kids with cancer a chance to celebrate: ‘I feel like a queen'
After being diagnosed with an aggressive and rare carcinoma tumor during her sophomore year in March, 16-year-old Jazzy missed her prom. Advertisement But, on Thursday afternoon, the Catskill teen got to walk a red carpet in a pink-beaded ball gown, pose for pics with new bestie and fellow patient Samantha,15, and boogie to 'Shout' and 'Dancing Queen' with her high school boyfriend Liam. 'We get to have our own little prom here,' said Jazzy, who is facing hearing loss from her chemotherapy. 'We have a new family here.' 8 Jazzy (left) and Samantha were thrilled to attend prom at Memorial Sloan Kettering. Tamara Beckwith Advertisement She was one of about 200 people —glammed up patients, families and staffers – in attendance at Memorial Sloan Kettering's Pediatric Prom, which was held in the transformed West Dining Room inside the renowned hospital. It was the 35th Pediatric Prom, which started as a small dance party in the hospital unit and has grown to an elaborate ball with fancy dresses, a photo booth, DJs, limos, a milk-and-cookies bar, face paint and lots of dancing. 'Our entire team is committed to making it a special and memorable day for everyone involved,' Rachel Corke, the director of hospital administration for MSK Kids, told The Post. 8 Staffers dress up and attend the prom alongside patients. Tamara Beckwith Advertisement Against the backdrop of glittery 'Starry Night' themed decorations, guests sipped ginger ale and juice and enjoyed mac and cheese and burgers that even the doctors OK'ed just this once. 'I don't feel like a princess — I feel like a queen,' exulted 7-year-old Maya in between bites of freshly popped popcorn from a festive cart. The tiara-clad tot has been battling neuroblastoma since she was 3 and underwent surgery two years ago to remove a tumor. Hospital staff danced alongside their brave young charges. 8 Patient Gini Beltran attended the event with fiance Juan Guillermo. Tamara Beckwith Advertisement 'This is everyone's favorite day of the year,' said Melissa Seidner, a 31-year-old administrative supervisor in the pediatric division at MSK. 'It's so fun to see all the patients enjoy themselves. It's a nice break from dealing with what we deal with.' She wore a jewel green gown that she'd selected from racks of donated dresses in a repurposed hospital rec room turned into 'Promingdale's' by the Society of MSK's Children's Committee. Maggie Kraus, a 17-year-old from Westchester who was diagnosed with leukemia this past November, rocked a soft purple frock with matching head scarf as she partied the afternoon away. 'I love princess dresses,' she said, vowing to wear it for her upcoming 18th birthday in July. 'I was really nervous I wouldn't be able to experience senior prom. But they pulled through.' 8 The Society of MSK's Children's Committee creates a 'Promingdale's' shop in a repurposed hospital rec room. Doree Lewak for NY Post 8 Patients and staffers get to choose from racks of donated clothing. Doree Lewak for NY Post Kraus was set to start her next round of chemo a few hours after prom, but she didn't let it — and the nausea it would likely bring about — take away from her enjoyment of the event. 'Let me have fun,' she said. Advertisement As the song 'I Will Survive' played poignantly in the background, the competitive equestrian relayed how her 'whole world got turned upside down' by her recent diagnosis. Doctors told her she wouldn't be able to ride horses for two years. 'I proved them wrong and I'm riding,' said the fearless teen, who volunteers to work with younger kids on the spectrum. 'I'm super-scared of needles, but I have to get used to it.' 8 Maggie Kraus was thrilled to find a violet gown. Tamara Beckwith Advertisement She shaved off her flowing brown hair — which she loved to dye bright colors — rather than waiting for the side effects of chemo to cause it to fall out. 'I wanted it to be my doing and not the cancer,' she said. Pediatric oncologist Dr. Andrew Kung told The Post that the prom exemplifies the philosophy at MSK, whose pediatric cancer center is ranked the best in the country and treats people up to age 40. 'This is one of the most special events for us,' he said. '[We're] not just about curing disease but caring for the patient and family.' Advertisement 8 The Rodriguez family — 6-year-old Alessia (second from left), mom Maite, dad Diego and little sister Vida — had a great time at the event. Tamara Beckwith 8 Jon Lyrick hopes to one day volunteer at the event. Tamara Beckwith Jon Lyrick was decked out in a show-stopping silver and black suit from Portabella. The 25-year-old from Crown Heights partied with friends as he told The Post that someday he'd 'love to come back to prom as a volunteer.' Advertisement Lyrick, who has undergone two bone marrow transplants, is feeling stronger every day. 'I love to have fun,' he told The Post between songs on the dance floor, where he happily spun around friends and IV poles. 'Today is a good day.'
